ST Eight Ling announced that the company signed an equity transfer framework agreement with Guangxi Detianhou Investment Co., Ltd., involving 36% of the shares of the target company, Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd.

Zhitongcaijing · 12/30/2025 11:25
ST Eight Ling announced that the company signed an equity transfer framework agreement with Guangxi Detianhou Investment Co., Ltd., involving 36% of the shares of the target company, Beijing Hongrun Tianyuan Gene Biotechnology Co., Ltd.